Abstract:The extracellular matrix (ECM) is a complex and dynamic network of cross-linked proteins and a fundamental building block in multicellular organisms. Our study investigates the impact of genes related to the ECM receptor interaction pathway on immune-targeted therapy and lung adenocarcinoma (LUAD) prognosis. This study obtained LUAD chip data (GSE68465, GSE31210, and GSE116959) from NCBI GEO. Moreover, the gene data associated with the ECM receptor interaction pathway was downloaded from the Molecular Signature Database. Differentially expressed genes were identified using GEO2R, followed by analyzing their correlation with immune cell infiltration. Univariate Cox regression analysis screened out ECM-related genes significantly related to the survival prognosis of LUAD patients. Additionally, Lasso regression and multivariate Cox regression analysis helped construct a prognostic model. Patients were stratified by risk score and survival analyses. The prognostic models were evaluated using receiver operating characteristic curves, and risk scores and prognosis associations were analyzed using univariate and multivariate Cox regression analyses. A core gene was selected for gene set enrichment analysis and CIBERSORT analysis to determine its function and tumor-infiltrating immune cell proportion, respectively. The results revealed that the most abundant pathways among differentially expressed genes in LUAD primarily involved the cell cycle, ECM receptor interaction, protein digestion and absorption, p53 signaling pathway, complement and coagulation cascade, and tyrosine metabolism. Two ECM-associated subtypes were identified by consensus clustering. Besides, an ECM-related prognostic model was validated to predict LUAD survival, and it was associated with the tumor immune microenvironment. Additional cross-analysis screened laminin subunit beta 1 (LAMB1) for further research. The survival time of LUAD patients with elevated LAMB1 expression was longer than those with low LAMB1 expression. Gene set enrichment analysis and CIBERSORT analyses revealed that LAMB1 expression correlated with tumor immune microenvironment. In conclusion, a prognostic model of LUAD patients depending on the ECM receptor interaction pathway was constructed. Screening out LAMB1 can become a prognostic risk factor for LUAD patients or a potential target during LUAD treatment.

Clinical Significance of CCBE1 Expression in Lung Cancer

Immuno-histochemical Expression and Significance of Extracellular Matrix Proteins and Integrin β1 in Non-small Cell Lung Cancer

Extracellular matrix expression in non small cell lung cancer and its relationship with neo-adjuvant chemotherapy

Expression of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 in Human Colorectal Cancer and Its Clinical Significance

CCBE1 Promotes Tumor Lymphangiogenesis and is Negatively Regulated by TGFβ Signaling in Colorectal Cancer.

COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer

LCN 1 is highly expressed in cholangiocarcinoma patients and indicates poor prognosis

CCBE1 is a Prognostic Biomarker and Contributes to Prostate Cancer Cell Progression.

Collagen type 1 alpha 1 chain is a novel predictive biomarker of poor progression-free survival and chemoresistance in metastatic lung cancer

Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.

CEACAM1 increased the lymphangiogenesis through miR-423-5p and NF- kB in Non-Small Cell Lung Cancer

Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma.

The promotion of non‐small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species

Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer

Expression of CD137L in non-small cell lung cancer tissues and its clinical significance

Expression of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Vascular Endothelial Growth Factor-C in Laryngeal Squamous Cell Carcinomas

Impact of Dysregulated LINC01559 and LINC01410 Expression on the Diagnosis and Survival of Non-Small Cell Lung Cancer

LETM1 is a Potential Biomarker of Prognosis in Lung Non-Small Cell Carcinoma

The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma

Clinical Significance of CK20, CK19, CEA Mrnas in Peripheral Blood from Lung Cancer Patients

The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients